Table 2.
Top 10 and bottom 10 ranking positions in the stability between donors for the expression of genes in each experimental condition.
| Rank | CTRL | OA-SF | IL1β HIGH | IL1β LOW | IL6 | IFNγ | MIX | All Samples |
|---|---|---|---|---|---|---|---|---|
| 1 | COL3A1 | TIMP1 | ADAMTS5 | MMP14 | CCL2 | COL3A1 | CTSK | ADAM15 |
| 2 | COL5A1 | MMP15 | TGFB | COL3A1 | CD44 | ADAMTS1 | COL5A2 | MMP14 |
| 3 | TGFB | MMP14 | NRG1 | CD44 | MMP14 | ICAM1 | TIMP2 | TIMP2 |
| 4 | NRG1 | ADAM15 | ADAMTS1 | TIMP1 | ADAM15 | NRG1 | CCL2 | COL5A2 |
| 5 | CTSK | TNFSF11 | CD44 | PDGFC | GDF9 | TIMP2 | HAS3 | TIMP1 |
| 6 | PLAU | NGF | ADAM15 | ANGPT2 | COL1A1 | ADAM15 | TGFB | ADAM12 |
| 7 | ADAMTS5 | FGF1 | HIF1 | TIMP2 | COL6A1 | COL5A1 | ADAMTS5 | ADAMTS1 |
| 8 | CCL2 | CTSS | PDGFC | TGFB | TNFSF11 | COL5A2 | FGF10 | COL3A1 |
| 9 | CD44 | COL6A1 | BDNF | MMP13 | TIMP2 | PLAU | MMP13 | HTRA1 |
| 10 | IL13 | BMP6 | TIMP2 | FGF1 | TIMP1 | HIF1 | ADAM15 | CD44 |
| 79 | MMP28 | MMP3 | HAS1 | ADAMTS16 | HAS1 | IL1RN | HAS2 | MMP1 |
| 80 | CXCL9 | HGF | COL2A1 | IGF2 | IL18 | MMP3 | IDO1 | IL11 |
| 81 | FGF10 | CXCL8 | EDN1 | COL10A1 | IGF2 | COL15A1 | ADAMTS16 | INOS |
| 82 | MMP3 | GH1 | COL10A1 | COL6A1 | CXCL10 | IL6 | ACAN | MMP3 |
| 83 | COL2A1 | IGF2 | IDO1 | ST14 | MMP3 | GH1 | IL11 | CXCL10 |
| 84 | IL6 | CXCL12 | IGF2 | ACAN | COL2A1 | COL2A1 | GH1 | COL15A1 |
| 85 | IL1RN | ST14 | CXCL10 | CXCL10 | IL6 | CXCL10 | COL6A1 | CCL5 |
| 86 | MMP1 | HAS1 | ANGPT2 | HAS1 | MMP1 | ADAMTS16 | NGF | IL6 |
| 87 | COL15A1 | FGF10 | ADAMTS4 | BMP4 | INOS | MMP1 | BMP4 | CXCL8 |
| 88 | CXCL8 | COL2A1 | IL1RN | COL15A1 | CXCL8 | CXCL8 | COL15A1 | CXCL9 |